首页 | 本学科首页   官方微博 | 高级检索  
     


Management of malignant pleural effusions
Authors:Lee Y C Gary  Light Richard W
Affiliation:The Centre for Respiratory Research, University College London,;The Oxford Pleural Diseases Unit, Oxford Centre for Respiratory Medicine, Churchill Hospital, Oxford, United Kingdom,;Asthma and Allergy Research Institute, The University of Western Australia, Perth, Australia, and;St Thomas Hospital and Vanderbilt University, Nashville, Tennessee, USA
Abstract:Abstract:   Malignant pleural effusion is a common clinical problem. Evacuation of the pleural fluid and prevention of its reaccumulation are the main aims of management. Pleurodesis should be attempted early, although considerable practice variations exist in the way it is performed. There is a lack of consensus among respiratory physicians worldwide on the optimal method and agent for pleurodesis. Talc remains the most commonly used pleurodesing compound in most countries. While talc produces a higher success rate than other compounds, it generates more side-effects. The association between talc and ARDS continues to be debated. Ambulatory small-bore pleural catheter drainage followed by intrapleural instillation of a pleurodesing agent is increasingly accepted as an alternative to conventional in-patient pleurodesis. Development of novel methods to control pleural fluid formation should be made a high priority in future pleural research.
Keywords:malignant    pleural effusion    pleurodesis
本文献已被 PubMed 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号